VIM and idiopathic pulmonary fibrosis: The firsthand evidence of extracellular and autoimmune forms of vimentin in IPF came from our study showing the presence of anti-vimentin antibodies that were associated with the worse clinical outcomes in the patients with IPF (Li et al., 2017a).